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Abstract 
 
Background Exposure to respirable crystalline silica (RCS) causes emphysema, airflow limitation, and 
chronic obstructive pulmonary disease (COPD). Slate miners are exposed to slate dust containing 
RCS but their COPD risk has not previously been studied. 
 
Aims To study the cumulative effect of mining on lung function and risk of COPD in a cohort of 
Welsh slate miners and whether these were independent of smoking and pneumoconiosis.  
 
Methods The study was based on a secondary analysis of Medical Research Council (MRC) survey 
data. COPD was defined as FEV1/FVC ratio< 0.7. We created multivariable models to assess the 
association between mining and lung function after adjusting for age and smoking status.  We used 
linear regression models for FEV1 and FVC and logistic regression for COPD.    
 
Results In the original MRC study, 1255 men participated (726 slate miners, 529 unexposed non-
miners). COPD was significantly more common in miners (n=213, 33%) than non-miners (n=120 
26%), p< 0.05. There was no statistically significant difference in risk of COPD between miners and 
non-miners when analysis was limited to non-smokers, or those without radiographic evidence of 
pneumoconiosis.  After adjustment for smoking, slate mining was associated with a reduction 
in %predicted FEV1 (β-coefficient = -3.97,95% CI: -6.65, -1.29) and FVC (β-coefficient = -2.32, 95% CI: 
-4.31, -0.33); and increased risk of COPD (OR 1.38, 95% CI: 1.06, 1.81).   
 
Conclusions Slate mining may reduce lung function and increase the incidence of COPD 
independently of smoking and pneumoconiosis. 
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INTRODUCTION 
Slate has been mined in North Wales for centuries and mines were important employers in the 
region, employing nearly 18,000 men at the industry’s peak in the late nineteenth century. Slate 
production has decreased over the years and many of the larger mines have closed.  However, 
smaller-scale mining producing tiles and aggregate continues.  Some of the closed mines have been 
transformed into visitor attractions and in recognition of the industry’s importance in Welsh history 
and culture. The Wales Millennium Centre in Cardiff is clad in slate tiles of different colours from 
mines in North Wales.  
 
Slate contains crystalline silica, mainly in the form of quartz, which can produce respirable dust when 
sawed or split; inhaled silica is fibrogenic and can cause silicosis and precipitate tuberculosis. A 
number of studies have been conducted in North Wales assessing the health of men working in the 
slate industry (1-3) and have variously observed high rates of both pneumoconiosis and tuberculosis. 
In 1975, the Medical Research Council (MRC) Pneumoconiosis Unit conducted a cross-sectional 
survey of slate miners and non-miners in the region (4) and reported an increased risk of 
pneumoconiosis in exposed miners and a high prevalence of radiological lesions suggestive of healed 
tuberculosis. A mortality analysis of this cohort of miners to 1998 (5) reported a clear excess death 
rate, chiefly from pneumoconiosis but also from other non-malignant respiratory disease, in slate 
workers compared to controls after adjustment for age and smoking habit. 
 
There is accumulating evidence that occupational respirable crystalline silica exposure (RCS) can also 
cause chronic obstructive pulmonary disease (COPD).  Studies of RCS and COPD have been limited to 
gold and other hard rock miners, coal miners, granite crushers, concrete workers (6) and uranium 
miners (7).  To our knowledge, no published studies have investigated COPD in slate miners. This 
analysis uses lung function data from the 1975 MRC survey to assess whether slate miners in North 
Wales have an increased risk of COPD. 
 METHODS 
The 1975 cross-sectional survey (MRC Pneumoconiosis Unit) took place in four slate mining and 
quarrying areas in North Wales: Blaenau Ffestiniog, Penygroes, Bethesda and Llanberis (4).  
Random samples of approximately 400 men were identified from the electoral rolls of each of the 
four areas and selected individuals were visited to assess their occupational history in the slate 
mining industry (n=1731). Those under the age of 30 who had never worked in slate mining were 
excluded (n=311) as were those who had lived outside the area for more than 20 years and had not 
worked in slate mining (n=150). The remaining men (n=1270) and those currently employed in slate 
mining (n=392) were invited to attend a clinic where the following data were collected: age, height, 
weight, smoking status, respiratory symptoms (using a bilingual translation of the MRC respiratory 
symptoms questionnaire), details of attendance at pneumoconiosis medical panels and chest clinics, 
exposure history to mouldy hay and domestic birds, occupational history, pneumoconiosis category 
based on posterior and lateral radiographs and lung function (FEV1 and FVC) measured without the 
use of a bronchodilator. Individuals with mixed dust exposure in their occupational history were 
excluded (n=307). 
 
Chest radiographs were assessed by three experienced readers using the ILO-U/C (1976) 
classification. Methods to resolve disagreements in the interpretation of radiographs are described 
elsewhere (4). Based on the assessments of the readers a score from 0 to 3 for “simple 
pneumoconiosis” was allocated using the method devised by Oldham (8).  
 
We did not consider our further analysis of survey data, described below, to pose any significant 
ethical issues and did not seek additional ethical approval. 
 
The main outcome variables we used were FEV1, FVC and COPD (yes/no) defined as FEV1/FVC<0.7, 
measured at the time of the survey. 
We report continuous variables as means (SD) or medians (IQR) based on their distribution. We used 
two-sample t-tests (assuming unequal variance) to compare normally distributed continuous 
variables between groups and, where variables are skewed, the Mann Whitney test. We present 
count data as frequencies and proportions and analyse them using the chi-square test for 
independence. We used linear regression models adjusting for age and height to generate sample 
specific percent predicted values for FEV1 and FVC.  
 
We used multivariable models to assess the association between mining and lung function after 
adjusting variably for age and smoking status. We used binary terms (ever vs never) for smoking and 
mining. To assess whether lung function measures were associated with duration of exposure, 
independently of age, we created a series of adjusted models stratified by age (tercile) and included 
in the models duration of exposure, age (continuous) and smoking status. To minimise the possibility 
that the reduced lung function in miners was due to pneumoconiosis, we excluded from this group 
any miner with radiological evidence of pneumoconiosis (n=72). We used linear regression models 
for FEV1 and FVC and logistic regression for COPD.  We present results from these models as β-
coefficients (95% CI) and odds ratios (95% CI), respectively. 
 
We performed all analyses using STATA v13 (College Station, US). 
 
RESULTS 
After initial screening, 1255 men agreed to participate in the survey: 726 (ever-) slate workers and 
529 unexposed men. The two groups were generally similar in age, height, weight and smoking 
history whereby most were either current or ex-smokers (Table 1).  
 
By the time of the 1975 survey, the duration of slate mining exposure ranged greatly from one to 72 
years and half of the miners were exposed for 15 years or more.  Workers with shorter durations of 
exposure tended to be younger reflecting both the duration of their working lives and the 
downscaling of the mining industry over the years (1-8 years of exposure – median age=32.5 years; 
9-24 years of exposure – median age=47.7 years; 25+ years of exposure – median age=63.1 years). 
 
Valid FEV1 and FVC data were available on 1117 and 1114 men respectively, in equal proportions for 
miners and non-miners. Both measures were lower in slate miners as was the FEV1/FVC ratio (Table 
2). When evaluated as ‘percent predicted’ values, the same patterns emerged. Almost a third of 
miners had COPD – defined as FEV1/FVC<0.7 - compared to a quarter of non-miners. We also 
explored whether each individual’s FEV1 was 1L or more below their predicted value, the criterion 
used in the UK Industrial Injuries Disablement scheme for the compensation of underground coal 
miners on the basis that it represents significant impairment of lung function and is associated with 
disabling breathlessness (9). Seven percent of miners and non-miners combined had such a deficit 
but the difference between slate miners (7%) and non-miners  (6%) was not statistically significant. 
 
The differences between miners who had never smoked and non-miners who had never smoked 
were not statistically significant (Table 3). Across sub-groups, rates of COPD were lower in never 
smokers regardless of mining exposure, and both FEV1 and FVC were higher in never smokers.  
 
The outputs of our multivariable models (Table 4) suggests that slate miners had reduced lung 
function and an increased risk of COPD regardless of smoking status. 
 
The trend for an increased risk of COPD in those with longer durations of exposure for all age groups 
was not statistically significant. Results for FEV1 and FVC percent predicted were less consistent 
although there was a clear exposure-response relationship for %predicted FEV1 among the oldest 
group. 
 
Slate miners without pneumoconiosis had a statistically significant, though modest, reduction in 
mean predicted FEV1 and a higher rate of COPD, which was not statistically significant (Table 5). 
 
DISCUSSION 
Our study found that those who worked in slate mining in North Wales had reduced lung function 
that cannot be wholly explained by smoking or pneumoconiosis. In never smokers, there were 
significant reductions in lung function in miners but no statistically significant increase in COPD.  This 
may be due in part to the small sample size (n=197).  Those without evidence of pneumoconiosis at 
the time of survey had small reductions in FEV1 %predicted but no statistically significant increase in 
COPD in miners.  
 
There were a number of strengths to our study. The unexposed group was selected from the same 
community and showed no meaningful differences in smoking habits or lung function measures.  
The similarities in smoking rates suggest that the groups are roughly similar socio-economically. The 
nature of mining in North Wales and the initial screening process ensured that those involved in 
slate mining were unlikely to have been exposed to coal dust. Additionally, lung function 
measurements were not collected through routine screening but were performed by the same study 
team at approximately the same time.  A number of limitations arise in particular from the cross-
sectional design. As individuals in the study had such a wide range in years of exposure we are 
covering a long period in slate mining history over which it would be natural to assume that 
exposures and working practices would have changed greatly. We cannot exclude the possibility that 
the nature of exposure was different in different mines. We did not have information necessary to 
examine this. Those surveyed represent a ‘survivor’ population (10) and it is probable that from the 
currently employed population some miners may have left because of respiratory diseases or 
industrial accidents before the survey.  Smoking data, although collected in the same way in both 
populations, was relatively crude and we did not have data on pack-years. 
 
The increased risk of COPD with increasing duration of exposure was not consistent across all age 
groups, and not always statistically significant. The data show that such differences are greatest 
when comparing those unexposed with those having the longest duration of exposure.  However, 
due to the high correlation between age and duration of exposure, disentangling the associations for 
each is difficult.  We note that Campbell et al (5) found that after allowing for the effects of smoking 
there were excess deaths from pneumoconiosis. Together with available radiographic data, the 
majority of which did not show pneumoconiosis, they suggested that there may have been a 
tendency to ascribe deaths to pneumoconiosis which were in fact due to underlying airways 
obstruction and a fatal exacerbation.  
 
Respirable slate dust in the North Wales mines contains between 13% and 32% respirable quartz (4). 
Recent measurements from two slate processing sites in North Wales (a slate crushing operation 
and production of roofing slates by sawing and hand-cleaving of blocks) reported personal RCS 
exposures to be between 0.1 and 0.3mg/m3 for the majority of measurements (11). Historic RCS 
measurements for slate miners in the MRC cohort are unavailable but are likely to have exceeded  
this. Interestingly, an excess of deaths from emphysema (SMR 1.59, p<0.05) was observed in the 
pre-1940 high exposure group (working in an environment with 0.2mg/m3 of RCS) of the Vermont 
Granite Mortality Study (12). The Vermont State Health Department established a threshold limit of 
10 mppcf (approximately 0.1mg/m3 of RCS) in 1938, which was achieved as an average exposure 
subsequent to 1940. After adjustment for smoking no significant association between FEV1 decline 
and RCS exposure was observed for Vermont granite workers who started work after 1940 
(13).  Modest FEV1 loss with obstructive pattern lung function that cannot be explained by 
pneumoconiosis or smoking has been observed in several studies of workers with RCS exposure (6) 
but clear exposure threshold limit values for COPD have not yet been established. Airflow limitation 
is thought to be mediated by emphysema, which post mortem studies have shown bears an 
exposure-response relationship with silica exposure (14), possibly arising from silica-induced 
inflammation with inactivation of alpha-1 antitrypsin (15).  Epidemiological studies of RCS and COPD 
include community and occupational cross-sectional studies and cohort studies where radiological 
imaging has not shown signs of silicosis.  For example, in Western Norway, an area that consists 
mainly of mountains that are rich in quartz minerals, a cross-sectional community survey found that 
13% (n=3445) of 26106 participants had self-reported occupational exposure to quartz. Each year of 
quartz exposure was associated with a 4.3ml (95% Cl 1.1 to 7.5 ml; p < 0.01) reduction in FEV1 after 
adjusting for age, atopy, asthma, wheezing, marital status, and other occupational exposures; the 
comparable reduction attributable to smoking was 6.9 ml (95% Cl 4.7 to 9.1 ml; p<0.01) from 
smoking 20 cigarettes/day for one year (16). Similarly, in a cohort study of 45 granite crushers from 
Uppsala, Sweden in which the mean cumulative amount of inhaled silica was 7mg over 22 years 
workers had, over a 12 year interval, a 5% greater decrease in FEV1 compared with referents 
matched, for age and smoking (17). A cross-sectional study of 144 concrete workers from the 
Netherlands found no significant change in FEV1 and only a small statistically significant change in 
FEV1/FVC associated with an average exposure of 0.566 silica-years (mg/m3/year) (18). A recent 
study of 1421 study subjects from the Wismut cohort of former uranium miners found that 
cumulative exposure of 1mg/m3-year respirable quartz leads to an average reduction in FEV1/FVC of 
3%% (p<0.001). (7) 
 
It is well established that while cigarette smoking is the most important single causal factor for 
developing COPD it is not the sole causal factor and occupational exposures are also causal. (19) We 
present the novel finding of airflow limitation that cannot be attributed to pneumoconiosis or 
smoking among workers exposed to RCS in slate mines; consistent with an accumulating body of 
evidence for an increased risk of COPD due to RCS. This is important for occupational health 
providers in the few remaining slate mines in North Wales and likely to become an emerging issue 
internationally in countries with significant slate mining operations such as Spain, Brazil, the US, and 
China. In view of the important interaction of smoking and RCS exposure in miners (14) the 
promotion of non-smoking by occupational health services is likely to be an important preventive 
strategy. Prospective research into workplace RCS exposure and COPD in these populations would 
be of value. 
 
Key points: 
• Slate miners are exposed to slate dust containing respirable crystalline silica but their risk of 
chronic obstructive pulmonary disease has not previously been studied.  
• Our results show an increased risk of COPD in slate miners, which is independent of smoking 
status and pneumoconiosis. 
• Occupational health providers to slate mines should seek to minimize slate dust exposure 
and consider workplace surveillance measures for COPD. 
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Table 1: Demographic characteristics of participants and exposure history of slate miners 
 
 All  Slate miners non-miners p-value 
N 1255 726 529  
Age at survey; mean (SD) 48.9 (16.1) 49.1 (17.1) 48.5 (14.8) NS 
Height (cm);  mean (SD) 169.6 (6.7) 169.1 (6.7) 170.3 (6.8) * 
Weight (kg): mean (SD) 72.5 (11.9) 72.2 (11.4) 73.1 (12.5) NS 
Smoking history; n (%) 
never 
ex-smoker 
current (incl. pipe) 
 
197 (16) 
293 (24) 
755 (60) 
 
106 (15) 
172 (24) 
441 (61) 
 
91 (17) 
121 (23) 
314 (60) 
 
NS 
Duration of slate mining 
(years); median (min, max) 
 
terciles; n (%) 
1-8 years 
9-24 years 
25+ years 
 
 
 
15 (1, 72) 
 
 
263 (36) 
221 (31) 
240 (33) 
 
- 
 
 
 
NS = non-significant, * p < 0.5, ** p < 0.1,  *** p <.01 
Table 2: Observed and predicted lung function measurements in slate miners and non-miners 
 All (n=1255) Slate miners 
(n=726) 
Non-miners 
(n=529) 
P-value 
FEV1 (L); mean (SD) 3.09 (1.00) 3.01 (1.03) 3.20 (0.93) ***  
FEV1 %predicted; mean 
(SD) 
100 (2.6) 98 (2.7) 103 (2.2) ** 
FVC (L); mean (SD) 4.16 (1.04) 4.08 (1.05) 4.28 (1.01) *** 
FVC %predicted; mean 
(SD) 
100 (16.6) 99 (16.8) 101 (16.3) * 
FEV1/FVC; median (IQR) 0.75 (0.68, 0.81) 0.75 (0.67, 0.81) 0.76 (0.70, 0.82) * 
COPD 
FEV1/FVC≥0.7; n(%) 
FEV1/FVC<0.7; n(%) 
 
781 (70) 
333 (30) 
 
437 (67) 
213 (3) 
 
344 (74) 
120 (26) 
 
* 
Observed FEV1 ≥1L below 
predicted for age and 
height; n(%) 
No 
Yes 
 
 
 
 
1039 (94) 
72 (7) 
 
 
 
604 (93) 
45 (77) 
 
 
 
435 (94) 
27 (6) 
 
 
 
NS 
 
NS = non-significant, * p < 0.5, ** p < 0.1,  *** p <.01
Table 3: Observed and predicted lung function measurements in slate miners and non-miners 
(never vs ever smokers) 
 
Analysis restricted to 
never smokers 
N=197 N=106 N=91  
FEV1 (L); mean (SD) 3.37 (0.99) 3.23 (1.12) 3.54 (0.78) * 
FEV1 %predicted; mean 
(SD) 
107  (21.9) 105 (21.5) 110 (22.1) NS 
FVC (L); mean (SD) 4.32 (1.05) 4.18 (1.15) 4.49 (0.88) * 
FVC %predicted; mean 
(SD) 
102 (16.7) 101 (17.3) 104 (15.7) NS 
FEV1/FVC; median (IQR) 0.80 (0.73, 0.85) 0.77 (0.71, 0.86) 0.81 (0.75, 0.84) NS 
COPD 
FEV1/FVC≥0.7; n(%) 
FEV1/FVC<0.7; n(%) 
 
 
144 (82) 
31 (18) 
 
75 (77) 
22 (23) 
 
69 (89) 
9 (12) 
 
NS 
Analysis restricted to 
ever smokers 
N=1048 N=613 N=435  
FEV1 (L); mean (SD) 3.04 (0.99) 2.98 (1.02) 3.14 (0.94) * 
FEV1 %predicted; mean 
(SD) 
99 (22.5) 97 (22.9) 101 (21.7) * 
FVC (L); mean (SD) 4.14 (1.03) 4.06 (1.03) 4.24 (1.03) ** 
FVC %predicted; mean 
(SD) 
100 (16.55) 99 (16.67) 101 (16.31) NS 
FEV1/FVC; median (IQR) 0.75 (0.68, 0.80) 0.74 (0.67, 0.80) 0.75 (0.69, 0.81) NS 
COPD 
FEV1/FVC≥0.7; n(%) 
FEV1/FVC<0.7; n(%) 
 
631 (68) 
298 (32) 
 
358 (66) 
188 (34) 
 
273 (71) 
110 (29) 
 
NS 
 
NS = non-significant, * p < 0.5, ** p < 0.1,  *** p <.01 
Table 4: Adjusted regression analyses assessing the associations between mining and smoking on 
measures of lung function and COPD 
 
 FEV1 %predicted;  
β (95% CI) 
FVC %predicted;  
β (95% CI) 
COPD (FEV1/FVC<0.7); 
OR (95% CI) 
All ages (N=1255) 
Mining -3.97 (-6.65, -1.29) -2.32 (-4.31, -0.33) 1.38 (1.06, 1.81) 
Smoking (ever) -8.07 (-11.68, -4.46) -2.55 (-5.23, 0.13) 2.18 (1.44, 3.29) 
 
Age<40 years (N=404) 
Age (years) 0.41 (0.16, 0.66) 0.45 (0.26, 0.64) 1.05 (0.99, 1.12) 
Mining (referent 
group: no exposure) 
1-8 years 
9 years or more 
 
 
0.51 (-2.92, 3.95) 
-2.00 (-6.18, 2.17) 
 
 
-0.13 (-2.70, 2.43) 
-0.89 (-4.00, 2.23) 
 
 
1.04 (0.45, 2.36) 
1.39 (0.58, 3.33) 
Smoking -3.14 (-6.78, 0.50) -1.00 (-3.72, 1.72) 1.25 (0.50, 3.15) 
 
Age 40-54 years (N=380) 
Age (years) -0.30 (-0.80, 0.21) -0.05 (-0.44, 0.33) 1.09 (1.03, 1.16) 
Mining (referent 
group: no exposure) 
1-8 years 
9-24 years 
25 years or more 
 
 
-8.10 (-14.38, -1.83) 
-2.42 (-7.92, 3.07) 
-5.77 (-12.18, 0.65) 
 
 
-5.47 (-10.27, -0.67) 
-0.37 (-4.55, 3.80) 
-3.13 (-8.01, 1.74) 
 
 
1.32 (0.66, 2.65) 
1.13 (0.60, 2.11) 
2.05 (1.03, 4.09) 
Smoking -11.18 (-17.75, -4.60) -3.32 (-8.31, 1.67) 3.17 (1.26, 7.98) 
 
Age 55+ years (N=467) 
Age (years) 0.15 (-0.29, 0.59) -0.31 (-0.64, 0.02) 1.06 (1.03, 1.10) 
Mining (referent 
group: no exposure) 
1-8 years 
9-24 years 
25 years or more 
 
 
2.73 (-9.06, 14.51) 
-6.66 (-15.43, 2.11) 
-7.65 (-14.47, -0.82) 
 
 
3.67 (-5.01, 12.35) 
-4.71 (-11.17, 1.75) 
-2.33 (-7.37, 2.72) 
 
 
1.07 (0.46, 2.46) 
1.26 (0.68, 2.34) 
1.55 (0.95, 2.52) 
Smoking -14.38 (-22.64, -6.12) -6.50 (-12.58, -0.42) 2.45 (1.32, 4.53) 
 
NS = non-significant, * p < 0.5, ** p < 0.1,  *** p <.01
Table 5: Analyses omitting miners with evidence of pneumoconiosis 
 
 All (n=1178) Slate miners 
without 
pneumoconiosis 
(n=649) 
Non-miners 
(n=529) 
P-value 
FEV1 (L); mean (SD) 3.15 (0.97) 3.11 (1.00) 3.20 (0.93) NS 
FEV1 %predicted; mean 
(SD) 
101 (21.9) 99 (21.5) 103 (22.2) * 
FVC (L); mean (SD) 4.23 (1.00) 4.19 (0.99) 4.28 (1.01) NS 
FVC %predicted; mean 
(SD) 
101 (15.9) 100 (15.6) 101 (16.3) NS 
FEV1/FVC; median (IQR) 0.76 (0.69, 0.81) 0.76 (0.70, 0.82) 0.75 (0.68, 0.81) NS 
COPD 
FEV1/FVC≥0.7; n(%) 
FEV1/FVC<0.7; n(%) 
 
 
751 (71) 
304 (29) 
 
407 (69) 
184 (31) 
 
344 (74) 
120 (26) 
 
NS 
 
NS = non-significant, * p < 0.5, ** p < 0.1,  *** p <.01 
 
 
